Levaquin and Urinary tract infection staphylococcal - a phase IV clinical study of FDA data

Summary:

Urinary tract infection staphylococcal is reported as a side effect among people who take Levaquin (levofloxacin), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Lopressor, and have Urinary tract infection.

The phase IV clinical study analyzes which people have Urinary tract infection staphylococcal when taking Levaquin. It is created by eHealthMe based on reports of 54,998 people who have side effects when taking Levaquin from the FDA, and is updated regularly.

What is Levaquin?

Levaquin has active ingredients of levofloxacin. It is often used in sinusitis. eHealthMe is studying from 56,638 Levaquin users. Check the latest studies of Levaquin.

What is Urinary tract infection staphylococcal?

Urinary tract infection staphylococcal is found to be associated with 122 drugs and 254 conditions by eHealthMe. Check the latest studies of Urinary tract infection staphylococcal.

On Jul, 15, 2026

54,998 people reported to have side effects when taking Levaquin.
Among them, 12 people (0.02%) have Urinary tract infection staphylococcal.

Could Levaquin cause Urinary tract infection staphylococcal?

Among these 12 people:

How long have people been on Levaquin when they have Urinary tract infection staphylococcal? *

What is the gender of people who have Urinary tract infection staphylococcal when taking Levaquin? *

female: 33.33 %
male: 66.67 %

What is the age of people who have Urinary tract infection staphylococcal when taking Levaquin? *

What are other drugs people take besides Levaquin? *

What are other side effects people have besides Urinary tract infection staphylococcal? *

Fever: 6 people, 50.00%
Thrombocytopenia (decrease of platelets in blood): 5 people, 41.67%
Acute Kidney Failure: 4 people, 33.33%
Weight Decreased: 4 people, 33.33%
Anaemia (lack of blood): 4 people, 33.33%
Urinary Tract Infection: 4 people, 33.33%
Confusional State: 4 people, 33.33%
Hypotension (abnormally low blood pressure): 4 people, 33.33%
Wound Infection Bacterial: 3 people, 25.00%
White Clot Syndrome (a complication of heparin therapy characterized by intravascular clots composed of platelet aggregates): 3 people, 25.00%

What are the existing conditions these people have? *

Urinary Tract Infection: 2 people, 16.67%
Pain: 1 person, 8.33%
Multiple Myeloma (cancer of the plasma cells): 1 person, 8.33%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 1 person, 8.33%
High Blood Cholesterol: 1 person, 8.33%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 8.33%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Levaquin and have Urinary tract infection staphylococcal?

- Check whether Urinary tract infection staphylococcal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Levaquin:

Levaquin (56,638 reports)

Urinary tract infection staphylococcal treatments and more:

Urinary tract infection staphylococcal (608 reports)

How severe was Urinary tract infection staphylococcal and when was it recovered:

Urinary tract infection staphylococcal in Levaquin

Expand to all the drugs that have ingredients of levofloxacin:

Urinary tract infection staphylococcal and drugs with ingredients of levofloxacin

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Levaquin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urinary tract infection staphylococcal:

Urinary tract infection staphylococcal (122 drugs)

Browse all the conditions that are associated with Urinary tract infection staphylococcal:

Urinary tract infection staphylococcal (254 conditions)

Related publications that referenced our studies

Bhuvan KC, ALrasheedy AA, Ibrahim MI, "A case report from Nepalese community pharmacy on levofloxacin induced severe abdominal pain", Saudi Pharmaceutical Journal, 2013 Jul .
MITTAL V, ARCHANA D, GUPTA A, SRIVASTAV U, CHANDRA V, SAXENA A, AGRAWAL P, "Aphasia: a Rarest Complication with a Well Known Drug Levofloxacin", Medical Science, 2013 Jan .
Bhuvan KC, ALrasheedy AA, Ibrahim MI, "A case report from Nepalese community pharmacy on levofloxacin induced severe abdominal pain", Saudi Pharmaceutical Journal, 2013 Jul .
MITTAL V, ARCHANA D, GUPTA A, SRIVASTAV U, CHANDRA V, SAXENA A, AGRAWAL P, "Aphasia: a Rarest Complication with a Well Known Drug Levofloxacin", Medical Science, 2013 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on levofloxacin (the active ingredients of Levaquin) and Levaquin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.